Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Powered By

Top 2 search results for "Xpovio" in Resources. To see all results and access other features, sign up for free.

... One part of the drug recognizes and binds to cancer cells, while the other part attacks and kills the cancer cell.Bispecific antibodies approved to treat relapsed or refractory DLBCL include apcoritamab-bysp (Epkinly) and glofitamab-gxbm (Columvi).Other drugs approved for relapsed/refractory DLBCL in certain situations include Selinexor (Xpovio) and ...
DLBCL Relapse Rate and Treatment Options
... One part of the drug recognizes and binds to cancer cells, while the other part attacks and kills the cancer cell.Bispecific antibodies approved to treat relapsed or refractory DLBCL include apcoritamab-bysp (Epkinly) and glofitamab-gxbm (Columvi).Other drugs approved for relapsed/refractory DLBCL in certain situations include Selinexor (Xpovio) and ...
... Selinexor (Xpovio) is a nuclear export inhibitor that can be used to treat recurrent diffuse large B-cell lymphoma (DLBCL).4. ImmunotherapyImmunotherapy treatments support the immune system in targeting and destroying lymphoma cells or slowing their growth. ...
8 Lymphoma Treatment Options: Chemo and Beyond
... Selinexor (Xpovio) is a nuclear export inhibitor that can be used to treat recurrent diffuse large B-cell lymphoma (DLBCL).4. ImmunotherapyImmunotherapy treatments support the immune system in targeting and destroying lymphoma cells or slowing their growth. ...